Drug Etiology of Aplastic Anemia and Related Dyscrasias
2 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
To determine the role of drugs in the etiology of aplastic anemia, agranulocytosis, and thrombocytopenic purpura. Drugs used in chemotherapy and immunotherapy were excluded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 1985
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 1985
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 1992
CompletedFirst Submitted
Initial submission to the registry
May 25, 2000
CompletedFirst Posted
Study publicly available on registry
May 26, 2000
CompletedMay 13, 2016
May 1, 2000
May 25, 2000
May 12, 2016
Conditions
Sponsors & Collaborators
Related Publications (1)
Kaufman DW, Kelly JP, Johannes CB, Sandler A, Harmon D, Stolley PD, Shapiro S. Acute thrombocytopenic purpura in relation to the use of drugs. Blood. 1993 Nov 1;82(9):2714-8.
PMID: 8219224BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
May 25, 2000
First Posted
May 26, 2000
Study Start
April 1, 1985
Study Completion
June 1, 1992
Last Updated
May 13, 2016
Record last verified: 2000-05